Pfizer Stock News

The recommendation now allows 12- to 15-year-olds to get the booster amid school closures and a rise in Omicron.

The FDA earlier this week issued emergency-use authorization for the Pfizer booster for kids ages 12 through 15.

The CDC recommends Pfizer''s booster shots for younger children as Covid-19 hospitalizations among U.S. kids soar.

Iqbal Singh Chahal, Mumbai''s municipal commissioner, says the Indian city''s vaccination rates are among the best in the world. He adds that its Covishield and Covaxin vaccines are "very effective" against Covid-19.

The US''s CDC said it expanded the eligibility of Pfizer Inc and BioNTech SE''s booster doses to those 12 to 15 years old

Booster doses of Pfizer-BioNTech''s COVID-19 vaccine are now available to adolescents age 12 to 15 after the Centers for Disease Control and Prevention on Wednesday endorsed a recommendation from an agency advisory panel. The agency now

US CDC advisory panel in favour of Pfizer vaccine booster for ages 12 to 15

Pfizer has entered into advance purchase agreements with multiple countries. Sources told ET that Pfizer is yet to apply for emergency use authorisation in India.

Pfizer says vaccine trial data for the under 5s will include results from booster shots; Italy tightens its vaccination rules as it reports a record rise in cases Novak Djokovics Australian Open hopes dashed after visa cancelled at airport Ministers must act now on NHS staffing crisis, health chiefs warn Grammy awards 2022 postponed indefinitely due to Omicron Covid vaccination doubt line receiving up to 1,000 calls a day in Netherlands Good morning and welcome to the Guardians rolling coverage of the coronavirus pandemic with me, Helen Livingstone. Pfizer has said it expects the latest results from its Covid vaccine clinical trial for children under the age of 5 which will include booster shots by April. Dr Alejandra Gurtman, a Pfizer vaccine researcher, said the company could even have data for the age group by the end of March. Continue reading

In non-hospitalized high-risk adults with COVID-19, Paxlovid was found to reduce the risk of hospitalization or death by 89% compared to placebo.

San Diego-based Allele Biotechnology and Pharmaceuticals Inc has resolved its patent dispute with Pfizer Inc and BioNTech SE over technology allegedly used in developing their COVID-19 vaccine, according to a filing late Tuesday in San Diego federal court.

A Pfizer Inc scientist said on Wednesday that the company should have data by late March or early April for children under the age of 5 from its ongoing clinical trial of the COVID-19 vaccine it developed with Germany''s BioNTech SE .

Teens ages 12 and up will be eligible to receive a COVID booster dose.

The U.S. is urging that everyone 12 and older get a COVID-19 booster as soon as they''re eligible, to help fight back the hugely contagious omicron mutant

The US Centers for Disease Control and Prevention updated its recommendations for the Pfizer/BioNTech Covid-19 vaccine booster on Wednesday to include children as young as 12, at least five months after they finish the primary vaccine series.